Thomas Spencer

55.4k total citations · 11 hit papers
404 papers, 39.3k citations indexed

About

Thomas Spencer is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Clinical Psychology. According to data from OpenAlex, Thomas Spencer has authored 404 papers receiving a total of 39.3k indexed citations (citations by other indexed papers that have themselves been cited), including 331 papers in Psychiatry and Mental health, 144 papers in Cognitive Neuroscience and 114 papers in Clinical Psychology. Recurrent topics in Thomas Spencer's work include Attention Deficit Hyperactivity Disorder (300 papers), Bipolar Disorder and Treatment (94 papers) and Child and Adolescent Psychosocial and Emotional Development (80 papers). Thomas Spencer is often cited by papers focused on Attention Deficit Hyperactivity Disorder (300 papers), Bipolar Disorder and Treatment (94 papers) and Child and Adolescent Psychosocial and Emotional Development (80 papers). Thomas Spencer collaborates with scholars based in United States, United Kingdom and Italy. Thomas Spencer's co-authors include Joseph Biederman, Stephen V. Faraone, Timothy E. Wilens, Eric Mick, Lenard A. Adler, Ronald C. Kessler, Michael C. Monuteaux, Kristina Secnik, JOSEPH BIEDERMAN and Mary J. Howes and has published in prestigious journals such as Nature, The Lancet and Physical Review Letters.

In The Last Decade

Thomas Spencer

396 papers receiving 37.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The World Health Organization adult ADHD self-report scale (ASRS): a short screening scale for use in the general population

2005 2.4k citations Ronald C. Kessler, Lenard A. Adler et al. profile →
The Prevalence and Correlates of Adult ADHD in the United States: Results From the National Comorbidity Survey Replication

2006 2.1k citations Ronald C. Kessler, Lenard A. Adler et al. profile →
Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder

1993 744 citations Joseph Biederman, Stephen V. Faraone et al. profile →
Future response of global coastal wetlands to sea-level rise

2018 706 citations Thomas Spencer et al. profile →
Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study

2006 671 citations Joseph Biederman, Michael C. Monuteaux et al. profile →
Pharmacotherapy of Attention-Deficit Hyperactivity Disorder across the Life Cycle

1996 619 citations Thomas Spencer, Timothy E. Wilens et al. profile →
Validity of the World Health Organization Adult ADHD Self‐Report Scale (ASRS) Screener in a representative sample of health plan members

2007 612 citations Ronald C. Kessler, Lenard A. Adler et al. profile →
Influence of Gender on Attention Deficit Hyperactivity Disorder in Children Referred to a Psychiatric Clinic

2002 597 citations Joseph Biederman, Eric Mick et al. profile →
Attention-deficit/hyperactivity disorder in adults: an overview

2000 536 citations Stephen V. Faraone, Joseph Biederman et al. profile →
Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Dose-Response Study

2001 529 citations Douglas E. Faries, Douglas K. Kelsey et al. profile →
Finite-Size Scaling and Correlation Lengths for Disordered Systems

1986 505 citations Thomas Spencer et al. profile →

Peers

Countries citing papers authored by Thomas Spencer

Since Specialization

Citations

This map shows the geographic impact of Thomas Spencer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Spencer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Spencer more than expected).

Fields of papers citing papers by Thomas Spencer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Spencer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Spencer. The network helps show where Thomas Spencer may publish in the future.

Co-authorship network of co-authors of Thomas Spencer

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Spencer. A scholar is included among the top collaborators of Thomas Spencer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Spencer. Thomas Spencer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	GABAA receptor availability in clinical high-risk and first-episode psychosis: a [11C]Ro15-4513 positron emission tomography study 2025 ·Molecular Psychiatry ·(unknown), Julia Schubert, Mariasavina Severino, (unknown), (unknown), (unknown), James Davies, Andrea De Micheli, Thomas Spencer, Paolo Fusar‐Poli, (unknown), Natasha Vorontsova, J Donocik, Eugenii A. Rabiner, Anthony A. Grace, Steven Williams, Philip McGuire, Mattia Veronese, Federico Turkheimer, Gemma Modinos	1
2	Collaborative Songwriting Intervention for Veterans with Post-Traumatic Stress Disorder 2020 ·The Journal of Alternative and Complementary Medicine ·Ronald E. Hirschberg, Louisa G. Sylvia, Edward C. Wright, (unknown), (unknown), (unknown), Elizabeth M. Goetter, (unknown), Kaloyan S. Tanev, Thomas Spencer	10
3	Telemedicine in the Management of ADHD: Literature Review of Telemedicine in ADHD 2019 ·Journal of Attention Disorders ·Thomas Spencer, (unknown), Joseph Biederman	37
4	Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial 2019 ·Journal of Child and Adolescent Psychopharmacology ·Robert L. Findling, Lenard A. Adler, Thomas Spencer, Robert Goldman, Seth C. Hopkins, Kenneth S. Koblan, Justine Kent, Jay Hsu, Antony Loebel	29
5	Preliminary Examination of the Reliability and Concurrent Validity of the Attention-Deficit/Hyperactivity Disorder Self-Report Scale v1.1 Symptom Checklist to Rate Symptoms of Attention-Deficit/Hyperactivity Disorder in Adolescents 2012 ·Journal of Child and Adolescent Psychopharmacology ·Lenard A. Adler, David M. Shaw, Thomas Spencer, Jeffrey H. Newcorn, Paul Hammerness, (unknown), (unknown), (unknown), Stephen V. Faraone	77
6	Is Response to OROS‐Methylphenidate Treatment Moderated by Treatment with Antidepressants or Psychiatric Comorbidity? A Secondary Analysis from a Large Randomized Double Blind Study of Adults with ADHD 2011 ·CNS Neuroscience & Therapeutics ·Joseph Biederman, Eric Mick, Thomas Spencer, Craig Surman, Stephen V. Faraone	13
7	Once-Daily Atomoxetine for Adult Attention-Deficit/Hyperactivity Disorder 2009 ·Journal of Clinical Psychopharmacology ·Lenard A. Adler, Thomas Spencer, Thomas E. Brown, James A. Holdnack, Keith E. Saylor, Kory Schuh, Paula T. Trzepacz, David W. Williams, Douglas K. Kelsey	117
8	Efficacy and Safety of Dexmethylphenidate Extended-Release Capsules Administered Once Daily to Children with Attention-Deficit/Hyperactivity Disorder 2009 ·Journal of Child and Adolescent Psychopharmacology ·Ann Childress, Thomas Spencer, Frank A. López, Ortrud Gerstner, (unknown), Rafael Muniz, Anke Post	27
9	Safety and Effectiveness of Coadministration of Guanfacine Extended Release and Psychostimulants in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder 2009 ·Journal of Child and Adolescent Psychopharmacology ·Thomas Spencer, (unknown), Lawrence Ginsberg, (unknown)	68
10	Effects of Atomoxetine on Growth in Children with Attention-Deficit/Hyperactivity Disorder Following up to Five Years of Treatment 2007 ·Journal of Child and Adolescent Psychopharmacology ·Thomas Spencer, Christopher J. Kratochvil, R. Bart Sangal, Keith E. Saylor, C. Everett Bailey, David W. Dunn, Daniel Geller, Charles D. Casat, Robert Lipetz, Rakesh K. Jain, Jeffrey H. Newcorn, Dustin Ruff, Peter D. Feldman, (unknown), Albert J. Allen	50
11	Atomoxetine Treatment in Children and Adolescents with Attention-Deficit Hyperactivity Disorder: What Are the Long-Term Health-Related Quality-of-Life Outcomes? 2006 ·Journal of Child and Adolescent Psychopharmacology ·Amy R. Perwien, Christopher J. Kratochvil, Douglas E. Faries, Brigette S. Vaughan, Thomas Spencer, Ronald T. Brown	56
12	The Prevalence and Effects of Adult Attention Deficit/Hyperactivity Disorder on Work Performance in a Nationally Representative Sample of Workers 2005 ·Journal of Occupational and Environmental Medicine ·Ronald C. Kessler, Lenard A. Adler, Minnie Ames, Russell A. Barkley, Howard G. Birnbaum, RN, Joseph A. Johnston, Thomas Spencer, (unknown)	257
13	Conceptualization and Assessment of Quality of Life for Adults with Attention- Deficit/Hyperactivity Disorder 2005 ·Meryl Brod, Amy R. Perwien, Lenard A. Adler, Thomas Spencer, Joseph A. Johnston	56
14	Long-Term Effects of Extended-Release Mixed Amphetamine Salts Treatment of Attention- Deficit/Hyperactivity Disorder on Growth 2005 ·Journal of Child and Adolescent Psychopharmacology ·Stephen V. Faraone, Joseph Biederman, Michael C. Monuteaux, Thomas Spencer	58
15	The course and outcome of attention-deficit/hyperactivity disorder. 2004 ·Eric Mick, Stephen V. Faraone, Joseph Biederman, Thomas Spencer	9
16	Patterns of Comorbidity and Dysfunction in Clinically Referred Preschool and School-Age Children with Bipolar Disorder 2003 ·Journal of Child and Adolescent Psychopharmacology ·Timothy E. Wilens, Joseph Biederman, (unknown), (unknown), Matthew C. Morris, Hadley Moore, Maribel Galdo, Thomas Spencer, Janet Wozniak	59
17	Pemoline Treatment of Adolescents with Attention Deficit Hyperactivity Disorder: A Short-Term Controlled Trial 2000 ·Journal of Child and Adolescent Psychopharmacology ·Jeff Q. Bostic, Joseph Biederman, Thomas Spencer, Timothy E. Wilens, Jefferson B. Prince, Michael C. Monuteaux, (unknown), (unknown), Mary Hatch	23
18	A Controlled Study of Nortriptyline in Children and Adolescents with Attention Deficit Hyperactivity Disorder 2000 ·Journal of Child and Adolescent Psychopharmacology ·Jefferson B. Prince, Timothy E. Wilens, Joseph Biederman, Thomas Spencer, Rachael Millstein, (unknown), Jeff Q. Bostic	67
19	Adjunctive Donepezil in Attention Deficit Hyperactivity Disorder Youth: Case Series 2000 ·Journal of Child and Adolescent Psychopharmacology ·Timothy E. Wilens, Joseph Biederman, (unknown), Thomas Spencer, Jeffrey B. Prince	43
20	Therapeutic Dilemmas in the Pharmacotherapy of Bipolar Depression in the Young 2000 ·Journal of Child and Adolescent Psychopharmacology ·Joseph Biederman, Eric Mick, Thomas Spencer, Timothy E. Wilens, Stephen V. Faraone	81

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact